title: Why is the New York Times writing so much about Alzheimer's disease therapies?
authors.forename: Tamas
authors.initials: T
authors.lastname: Bartfai
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy* / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism; D006801:Humans; D009518:New York; D009524:Newspapers as Topic; D017063:Outcome Assessment, Health Care / Q000191:economics; D010446:Peptide Fragments / Q000378:metabolism; D011639:Public Opinion
chemical_list: D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; C078592:amyloid beta-protein (1-40)